KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-70460 | Pharmaceuticals and Medical
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Klebsiella pneumoniae infection drugs Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET
7.1 GLOBAL KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA KLEBSIELLA PNEUMONIAE INFECTION DRUGS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Peptilogics Inc
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Debiopharm International SA
16.3 Pfizer Inc
16.4 Kyorin Pharmaceutical Co Ltd
16.5 Innovation Pharmaceuticals Inc
16.6 Syntiron LLC
16.7 Shionogi & Co Ltd
16.8 Acies Bio doo
16.9 FOB Synthesis Inc
16.10 Appili Therapeutics
16.11 Nosopharm SAS
16.12 Phico Therapeutics Ltd
16.13 ImmunoClin Corp
16.14 F Hoffmann-La Roche Ltd
16.15 Evaxion Biotech ApS
16.16 Tetraphase Pharmaceuticals Inc
16.17 Melinta Therapeutics Inc
16.18 Sarepta Therapeutics Inc
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Major Types CoveredCC-1807
ATI-1503
Other types
Cefiderocol
EBX-004
Debio-1454
CA-824
Major Downstream Industry Covered
clinic
hospital
Other applications
Companies
Peptilogics Inc
Debiopharm International SA
Pfizer Inc
Kyorin Pharmaceutical Co Ltd
Innovation Pharmaceuticals Inc
Syntiron LLC
Shionogi & Co Ltd
Acies Bio doo
FOB Synthesis Inc
Appili Therapeutics
Nosopharm SAS
Phico Therapeutics Ltd
ImmunoClin Corp
F Hoffmann-La Roche Ltd
Evaxion Biotech ApS
Tetraphase Pharmaceuticals Inc
Melinta Therapeutics Inc
Sarepta Therapeutics Inc
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.